BaroSense, Inc.

BaroSense, Inc.

Founded 2001 3 employees Series D Total: $50.64M Biotechnology, Health Care +2

BaroSense, Inc. is a medical device company based in Redwood City, CA, specializing in the research and development of innovative, minimally invasive medical devices for treating obesity. Founded in 2001, BaroSense is dedicated to creating minimally invasive therapeutic weight loss procedures and devices that offer a safe, simple, effective, and reversible alternative to surgical obesity treatment. The company operates in the Biotechnology, Health Care, Health and Wellness, and Medical Devices industries. Its most recent Series D investment of $27.00M was secured on 24 August 2009, with participation from notable investors such as iNovia Capital, Frazier Healthcare Partners, Delphi Ventures, Invesco, RWI Ventures, University Growth Fund, Synergy Life Science Partner, and Pappas Ventures. BaroSense's commitment to providing a less invasive approach to weight loss aligns with the growing demand for non-surgical alternatives and positions the company as a significant player in the evolving obesity treatment market.

Funding Stage	Amount	Investors	Lead Investors	Date
Series D	$27.00M	8	iNovia Capital, Frazier Healthcare Partners +6	24 Aug 2009
Series C	$11.21M	2	Frazier Healthcare Partners, Delphi Ventures	05 Dec 2007
Series B	$6.20M	-		22 Dec 2004
Series A	$6.23M	-		22 Jul 2002

Funding Stage

Amount

Investors

Lead Investors

Date

Series D

$27.00M

iNovia Capital, Frazier Healthcare Partners +6

24 Aug 2009

Series C

$11.21M

Frazier Healthcare Partners, Delphi Ventures

05 Dec 2007

Series B

$6.20M

22 Dec 2004

Series A

$6.23M

22 Jul 2002

FAQ About BaroSense, Inc.

BaroSense Inc. is a medical device company headquartered in Redwood City, CA, that focuses on the research and development of innovative, minimally invasive medical devices for the treatment of obesity. BaroSense is committed to the development of minimally invasive therapeutic weight loss procedure...

BaroSense, Inc. was founded in 2001.

BaroSense, Inc. operates in Biotechnology, Health Care, Health and Wellness and Medical Devices.

BaroSense, Inc. has approximately 3 employees.

BaroSense, Inc. has completed 4 funding rounds, raising a total of $50.64M. The latest funding stage is Series D.

Top alternatives and competitors to BaroSense, Inc. include ReShape Lifesciences Inc., Apollo Endosurgery, Aspire Bariatrics, Wenzel Spine, Prime Surgicare. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

BaroSense, Inc. and ReShape Lifesciences Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About BaroSense, Inc.

Funding Rounds & Investors (4)

BaroSense, Inc. Alternatives & Competitors

FAQ About BaroSense, Inc.